首页> 外国专利> BLOOD TRANSCRIPTIONAL SIGNATURES OF ACTIVE PULMONARY TUBERCULOSIS AND SARCOIDOSIS

BLOOD TRANSCRIPTIONAL SIGNATURES OF ACTIVE PULMONARY TUBERCULOSIS AND SARCOIDOSIS

机译:活动性肺结核和沙门氏菌病的血液转录特征

摘要

The present invention includes a method of determining a lung disease from a patient suspected of sarcoidosis, tuberculosis, lung cancer or pneumonia comprising: obtaining a sample from whole blood of the patient suspected of sarcoidosis, tuberculosis, lung cancer or pneumonia; detecting expression of (although not exclusive) six or more disease genes, markers, or probes selected from SEQ ID NOS.: 1 to 1446, wherein increased expression of mRNA of upregulated sarcoidosis, tuberculosis, lung cancer and pneumonia markers of SEQ ID NOS.: 1 to 1446 and/or decreased expression of mRNA of downregulated sarcoidosis, tuberculosis, lung cancer or pneumonia markers of SEQ ID NOS.: 1 to 1446 relative to the expression of the mRNAs from a normal sample; and determining the lung disease based on the expression level of the six or more disease markers of SEQ ID NOS.: 1 to 1446 based on a comparison of the expression level of sarcoidosis, tuberculosis, lung cancer, and pneumonia.
机译:本发明包括从疑似结节病,结核,肺癌或肺炎的患者中确定肺部疾病的方法,该方法包括:从疑似结节病,结核,肺癌或肺炎的患者的全血中获取样品;检测(尽管不是排他的)六个或更多个选自SEQ ID NOS.1至1446的疾病基因,标记或探针的表达,其中上调的SEQ ID NOS的结节病,肺结核,肺癌和肺炎标记物的mRNA表达增加。 :相对于正常样品的mRNA的表达,SEQ ID NO:1至1446的结节病,结核,肺癌或肺炎标记的下调的mRNA的表达降低;和/或mRNA的表达降低。并基于结节病,结核,肺癌和肺炎的表达水平的比较,根据SEQ ID NOS .: 1至1446中六个或更多疾病标记的表达水平确定肺部疾病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号